Amicogen's IPO

Amicogen raised a round of funding on September 12, 2013. Investors include Public.

Amicogen (아미코젠) is an industrial biotechnology company focusing on Specialty Enzymes (CX, SP, etc.) and Bio-ingredient (N-Acetylglucosamine, Pinitol/D-Chiro-inositol, Collagen Peptide/ Collage…

Articles about Amicogen's IPO: